These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


203 related items for PubMed ID: 487809

  • 1. Interruption of pregnancy with vaginal suppositories containing 16,16-dimethyl-trans-delta 2-prostaglandin E1 methyl ester.
    Wagatsuma T, Tabuchi T, Tabei T, Kaku R.
    Contraception; 1979 Jun; 19(6):591-7. PubMed ID: 487809
    [Abstract] [Full Text] [Related]

  • 2. Abortifacient effect and uterine cervix-dilating action of 16, 16-dimethyl trans delta 2 PGE1 methyl ester (ONO 802) in the form of a vaginal suppository (a randomized, double-blind, controlled study in the second trimester of pregnancy).
    Sakamoto S, Satoh K, Nishiya I, Kunimoto K, Chimura T, Oda T, Takeuchi S, Satoh Y, Iizuka R, Kobayashi T, Takagi S, Yoshida T, Tomoda Y, Ninagawa T, Kurachi K, Tanizawa O, Tojo S, Mochizuki M, Maeda K, Tominaga Y, Torigoe T, Koresawa M, Taki I, Hamada T.
    Prostaglandins Leukot Med; 1982 Sep; 9(3):349-61. PubMed ID: 6752961
    [Abstract] [Full Text] [Related]

  • 3. The use of prostaglandin E1 analogue pessaries in patients having first trimester induced abortions.
    Nakano R, Hata H, Sasaki K, Yamoto M.
    Br J Obstet Gynaecol; 1980 Apr; 87(4):287-91. PubMed ID: 7426498
    [Abstract] [Full Text] [Related]

  • 4. Controlled study of 16,16-dimethyl-trans-delta 2 prostaglandin E1 methyl ester vaginal pessaries prior to suction termination of first trimester pregnancies.
    Fisher PR, Taylor JH.
    Br J Obstet Gynaecol; 1984 Nov; 91(11):1141-4. PubMed ID: 6388625
    [Abstract] [Full Text] [Related]

  • 5. The use of 16-16 dimethyl trans delta 2 PGE1 methyl ester (ONO 802) vaginal suppositories for the termination of early pregnancy. A comparative study.
    Smith SK, Baird DT.
    Br J Obstet Gynaecol; 1980 Aug; 87(8):712-7. PubMed ID: 7426533
    [Abstract] [Full Text] [Related]

  • 6. Mid-trimester abortion by vaginal administration of 9-deoxo-16, 16-dimethyl-9-methylene-PGE2.
    Bygdeman M, Christensen N, Gréen K, Lundström V.
    Contraception; 1980 Aug; 22(2):153-64. PubMed ID: 7449380
    [Abstract] [Full Text] [Related]

  • 7. Termination of early pregnancy by ONO-802 suppositories (16,16-dimethyl-trans-delta2-PGE1 methyl ester).
    Takagi S, Sakata H, Yoshida T, Den K, Fujii TK, Amemiya H, Tomita M.
    Prostaglandins; 1978 May; 15(5):913-9. PubMed ID: 704915
    [Abstract] [Full Text] [Related]

  • 8. Termination of early gestation with 9-deoxo-16,16-dimethyl-9-methylene prostaglandin E2.
    Brenner PF, Marrs RP, Roy S, Mishell DR.
    Contraception; 1982 Sep; 26(3):261-77. PubMed ID: 6184197
    [Abstract] [Full Text] [Related]

  • 9. Termination of early gestation with (15S)-15-methyl prostaglandin F2 alpha methyl ester vaginal suppositories.
    Marrs RP, Brenner PF, Roy S, Mishell DR.
    Contraception; 1981 Dec; 24(6):617-30. PubMed ID: 6173157
    [Abstract] [Full Text] [Related]

  • 10. Cervical dilatation with 16,16-dimethyl-trans-delta 2-PGE1 methyl ester (Cervagem) prior to vacuum aspiration. A double-blind, placebo-controlled randomized study.
    Christensen NJ, Bygdeman M.
    Contraception; 1984 May; 29(5):457-64. PubMed ID: 6378517
    [Abstract] [Full Text] [Related]

  • 11. Post-conceptional induction of menses with a single vaginal suppository of (15S)-15-methyl prostaglandin F2 alpha methyl ester.
    Scher J, Jeng DY, Kerenyi TD.
    Prostaglandins; 1980 Sep; 20(3):469-79. PubMed ID: 6252575
    [Abstract] [Full Text] [Related]

  • 12. Termination of early pregnancy by a single-dose 3.0 mg 15-methyl PGF2alpha methyl ester vaginal suppository.
    Mandelin M.
    Prostaglandins; 1978 Jul; 16(1):143-52. PubMed ID: 704921
    [Abstract] [Full Text] [Related]

  • 13. Menstrual regulation with prostaglandin (Pg ONO 802) in Indonesia.
    Agoestina T, Sastrawinata S, Prayitno W, Gonta P.
    Int J Gynaecol Obstet; 1984 Oct; 22(5):403-9. PubMed ID: 6151928
    [Abstract] [Full Text] [Related]

  • 14. A Gemeprost vaginal suppository for cervical priming prior to termination of first trimester pregnancy.
    Kajanoja P, Mandelin M, Mäkilä UM, Ylikorkala O, Felding C, Somell C, Olund A, Pedersen H.
    Contraception; 1984 Mar; 29(3):251-60. PubMed ID: 6539662
    [Abstract] [Full Text] [Related]

  • 15. A comparison of two stable prostaglandin E analogues for termination of early pregnancy and for cervical dilatation.
    Bygdeman M, Bremme K, Christensen N, Lundström V, Gréen K.
    Contraception; 1980 Nov; 22(5):471-83. PubMed ID: 7471738
    [Abstract] [Full Text] [Related]

  • 16. Effect of 15(s)15-methyl-PGF2alpha-methyl ester vaginal suppositories on circulating hormone levels in early pregnancy.
    Puri CP, Laumas V, Agarwal N, Zoremthangi, Hingorani V, Laumas KR.
    Prostaglandins; 1977 Feb; 13(2):363-73. PubMed ID: 847240
    [Abstract] [Full Text] [Related]

  • 17. The vaginal administration of 9-deoxo-16,16-dimethyl-9-methylene PGE2 for second trimester abortion.
    Ballard CA.
    Contraception; 1981 Aug; 24(2):151-7. PubMed ID: 7297067
    [Abstract] [Full Text] [Related]

  • 18. Midtrimester abortion induced by serial intravaginal administration of prostaglandin E2 suppositories in conjunction with a contraceptive diaphragm.
    Lauersen NH, Wilson KH.
    Prostaglandins; 1975 Jul; 10(1):139-50. PubMed ID: 1153798
    [Abstract] [Full Text] [Related]

  • 19. The effect of a 15(S)-15-methyl prostaglandin F2 alpha (methyl ester) suppository upon termination of early pregnancy.
    Roux JF, Southern E, Gutknecht G.
    Contraception; 1980 Jul; 22(1):57-61. PubMed ID: 7418407
    [Abstract] [Full Text] [Related]

  • 20. Mid-trimester therapeutic abortion by vaginal suppository of 16, 16-dimethyl-trans-delta 2-prostaglandin E1.
    Kato K, Furuya K, Makimura N, Nagata I, Ishida M, Seki K.
    Asia Oceania J Obstet Gynaecol; 1985 Jun; 11(2):163-7. PubMed ID: 4038169
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.